Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced results of an in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback